Pacira BioSciences, Inc. (PCRX) earnings · rev $726.4M
These earnings events as JSON? API free 100/dayPacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This PCRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PCRX revenue for 2025-12-31 was $726.4M. Net income was $7.0M. Revenue was up 3.6% from 2024-12-31 to 2025-12-31. PCRX currently screens at market cap $890.8M.
When the next PCRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 3.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PCRX research stays on the stock page; the tape stays on the quote page.
PCRX earnings FAQ
What are PCRX's latest revenue and net income?
Latest cached Pacira BioSciences, Inc. (PCRX) revenue for Dec 31, 2025 was $726.4M. Net income was $7.0M. Statements: https://lician.com/financials/pcrx
What is PCRX's latest diluted EPS?
Latest cached Pacira BioSciences, Inc. (PCRX) diluted EPS for Dec 31, 2025 was $0.16.
What period does the latest PCRX earnings print cover?
The latest cached Pacira BioSciences, Inc. (PCRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PCRX revenue change from the prior cached period?
Cached Pacira BioSciences, Inc. (PCRX) revenue was up 3.6% from $701.0M (Dec 31, 2024) to $726.4M (Dec 31, 2025). Statements: https://lician.com/financials/pcrx
Where are PCRX earnings listed?
Cached earnings facts for Pacira BioSciences, Inc. (PCRX) are listed at https://lician.com/earnings/pcrx. Statements: https://lician.com/financials/pcrx
Not investment advice.